Andere Sprachen Pharmacolog i Uppsala AB

Aktien

A3DWNW

SE0019071812

PERP B

Markt geschlossen - Nasdaq Stockholm Andere Börsenplätze 17:29:42 02.05.2024			% 5 Tage	% 1. Jan.
0,0832 ^SEK	-9,37 %		-14,23 %	+47,00 %

23.04.	Pharmacolog i Uppsala AB (publ) wird sein Börsenkürzel von PHLOG B auf PERP B ändern	CI
04.04.	Pharmacolog i Uppsala AB (publ) gibt die Ernennung von Anders Hedlund zum Interims-CEO mit Wirkung zum 1. Mai 2024 bekannt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) appoints Camilla Lönn as CFO	24.04.
Perpetua Medical AB Appoints Camilla Lonn as CFO	24.04.
Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) announces its first day of trading on Nasdaq First North under its new company name	23.04.
Pharmacolog i Uppsala AB will Change its Ticker to PERP B from PHLOG B	23.04.
Pharmacolog i Uppsala AB will Change its Name to Perpetua Medical AB	23.04.
ANNOUNCEMENT FROM THE EXTRAORDINARY GENERAL MEETING OF PHARMACOLOG I UPPSALA AB ON APRIL 16, 2024	16.04.
Pharmacolog publishes annual report for 2023	16.04.
Nolsterby Invest AB has increased its holding in Pharmacolog	08.04.
Pharmacolog announces the appointment of Anders Hedlund as interim CEO	04.04.
Pharmacolog i Uppsala AB Announces the Appointment of Anders Hedlund as Interim CEO, Effective from May 1, 2024	04.04.
NOTICE TO EXTRAORDINARY GENERAL MEETING IN PHARMACOLOG I UPPSALA AB (PUBL)	14.03.
Pharmacolog provides update on new business direction and proposes name change	14.03.
Pharmacolog announces upcoming change in management	01.03.
Pharmacolog Announces Resignation of Lars Gusch as CEO, Effective from April 30, 2024	01.03.
Warrants of series TO3 were subscribed to approximately 90.4 percent and Pharmacolog receives approximately SEK 2.3 million	27.02.
Major shareholder in Pharmacolog exercises warrants of series TO3 for at least approximately SEK 0.54 million	20.02.
The last day of trading with warrants of series TO3 in Pharmacolog is today, February 20, 2024	20.02.
Year-end bulletin Pharmacolog 2023	16.02.
Pharmacolog i Uppsala AB Reports Earnings Results for the Full Year Ended December 31, 2023	16.02.
Pharmacolog i Uppsala AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	16.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Pharmacolog i Uppsala AB

Aktien

A3DWNW

SE0019071812

PERP B

Andere Sprachen

Filter